Abbott Labs to Acquire Kos

From the Department of Headlines that caused a double take....

Abbott Labs to Acquire Kos Abbott Labs agreed to pay $3.7 billion for Kos Pharmaceuticals, which makes a drug that raises so-called good cholesterol.


Tags: , /

About this Entry

This page contains a single entry by Seth A. published on November 6, 2006 10:36 PM.

Weapons of Mass Disintegration was the previous entry in this blog.

What to do now is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Pages

Powered by Movable Type 4.37